Cayman | Jotup

CaymanStory.com Personal Branding Master Class for Cayman Islands Entrepreneurs Second Batch 2024

Retrieved on:

星期一, 三月 25, 2024

Cayman Enterprise City, Miss, Partnership, Knowledge, Social media, Small business, Cayman, Curriculum, INC

Grand Cayman, Cayman Islands , March 25, 2024 (GLOBE NEWSWIRE) -- "Offered via Zoom from George Town, Cayman Islands, this exciting development provides entrepreneurs and small business owners across the Cayman Islands with a unique opportunity.

Key Points:

Grand Cayman, Cayman Islands , March 25, 2024 (GLOBE NEWSWIRE) -- "Offered via Zoom from George Town, Cayman Islands, this exciting development provides entrepreneurs and small business owners across the Cayman Islands with a unique opportunity.
This is the second batch sponsored by CaymanStory.com, a rising digital marketing startup led by Jaci Patrick , the former Miss World Cayman Islands.
Expert Instruction: Led by renowned Forbes Council member, CEO, and founder of Storytellers, INC, a Cayman Islands company in the Cayman Enterprise City, Qamar Zaman, this master class promises to deliver actionable insights and strategies drawn from years of successful industry experience.
No Cost: The master class is offered completely free, providing unparalleled access to premium personal branding education.

Spring Investments SA Appoints Jackie Ineke as New Chief Investment Officer

Retrieved on:

星期一, 四月 8, 2024

Finance, Banking, Professional Services, Other Professional Services, Asset Management, Growth, Environment, UBS, Financial services, Bank, Research, AT1, Morgan Stanley, SBC, Investment, Cayman, Security (finance)

Spring Investments SA, a Swiss boutique fixed-income portfolio management company, proudly announces the appointment of Ms. Jackie Ineke as the firm’s Chief Investment Officer.

Key Points:

Spring Investments SA, a Swiss boutique fixed-income portfolio management company, proudly announces the appointment of Ms. Jackie Ineke as the firm’s Chief Investment Officer.
Echoing this sentiment, Mr. Snir Gliksman, CEO of Spring Investments SA, emphasized, "In today's investment environment, there is a growing demand for fixed-income solutions among institutional and professional investors.
Expressing her enthusiasm, Ms. Ineke remarked, "I am delighted to take up this unique opportunity at Spring Investments.
Spring Investments SA is a licensed portfolio management firm regulated by the Swiss Financial Market Supervisory Authority FINMA.

CASI PHARMACEUTICALS REPORTS DEVELOPMENT RELATING TO ITS DISPUTES WITH JUVENTAS

Retrieved on:

星期一, 四月 8, 2024

CASI, Therapy, Cayman, CASI Pharmaceuticals, Form 6-K

BEIJING, April 8, 2024 /PRNewswire/ -- CASI Pharmaceuticals, Inc. (Nasdaq: CASI), a Cayman incorporated biopharmaceutical company focused on developing and commercializing innovative therapeutics and pharmaceutical products, today reported that it has furnished a current report on Form 6-K to disclose material development relating to its dispute with Juventas.

Key Points:

BEIJING, April 8, 2024 /PRNewswire/ -- CASI Pharmaceuticals, Inc. (Nasdaq: CASI), a Cayman incorporated biopharmaceutical company focused on developing and commercializing innovative therapeutics and pharmaceutical products, today reported that it has furnished a current report on Form 6-K to disclose material development relating to its dispute with Juventas.
For details, please visit below link:

Graphjet Technology, The World’s Only Direct Biomass-to-Graphite Producer, Completes Transaction and Will Begin Trading on Nasdaq

Retrieved on:

星期四, 三月 14, 2024

Aiden, EV, Growth, EF Hutton, Business, LLP, Carbon, Graphite, OTC, Water, Optimism, Cayman, Biomass, Carbon fibers

KUALA LUMPUR, Malaysia, March 14, 2024 (GLOBE NEWSWIRE) -- Graphjet Technology (“Graphjet” or “the Company”), a leading developer of patented technologies to produce graphite and graphene directly from agricultural waste, and Energem Corp. (“Energem”) (Nasdaq: ENCP, ENCPW) today announced they have closed their previously announced business combination (“the Business Combination”). The transaction, which was approved on February 28, 2024, by Energem stockholders, creates the only pure-play publicly traded direct biomass-to-graphite company, establishing the Company as the leading source of graphite and graphene for the U.S market.

Key Points:

Beginning tomorrow, March 15, 2024, Graphjet’s ordinary shares will start trading on Nasdaq under the ticker symbol “GTI.” Graphjet’s warrants will be delisted from Nasdaq and begin trading on the OTC market under the symbol “GTIWW” on March 15, 2024.
Graphjet’s CEO, Lee Ping Wei (Aiden Lee), and the rest of the Company’s current management team are expected to remain in leadership positions.
“We are thrilled to list Graphjet on the Nasdaq, particularly at this crucial moment of critical material demand and limited availability for the U.S. market,” said Mr. Lee.
“On the heels of China’s decision to restrict exports on graphite, we continue to engage in advanced conversations with customers.

CIFC’s CLO Initiative for Change Makes Third Donation; Marks Second Donation to TEAK Fellowship

Retrieved on:

星期三, 三月 27, 2024

For this donation, CIFC has partnered with the deal parties of its latest CLO, CIFC Funding 2024-II, including RBC Capital Markets, Appleby (Cayman) Ltd, Allen & Overy LLP, and Milbank LLP, to make a collective contribution of $225,000 to the TEAK Fellowship (“TEAK”).

Key Points:

For this donation, CIFC has partnered with the deal parties of its latest CLO, CIFC Funding 2024-II, including RBC Capital Markets, Appleby (Cayman) Ltd, Allen & Overy LLP, and Milbank LLP, to make a collective contribution of $225,000 to the TEAK Fellowship (“TEAK”).
This donation is the second $225,000 financial contribution CIFC’s CLO Initiative for Change has made to TEAK, a free, outcomes-driven academic and career access program for students located in New York City, and builds upon CIFC’s existing partnership with the organization.
This workshop, which CIFC will host again this summer, coupled with the CLO Initiative for Change’s second financial contribution to TEAK, will allow TEAK to continue to unlock access to outstanding education and transformative experiences for students.
Today’s donation to TEAK is the third donation made on behalf of the program and the second donation to TEAK by the program.

Nuvation Bio to Acquire AnHeart Therapeutics in All-Stock Transaction

Retrieved on:

星期一, 三月 25, 2024

Nuvation Bio Inc. (NYSE: NUVB), a biopharmaceutical company tackling some of the greatest unmet needs in oncology by developing differentiated and novel therapeutic candidates, and AnHeart Therapeutics Ltd. (AnHeart), a global clinical-stage biopharmaceutical company developing novel precision therapies for people with cancer, today announced that the companies have entered into a definitive agreement for Nuvation Bio to acquire AnHeart in an all-stock transaction (the Acquisition).

Key Points:

Nuvation Bio Inc. (NYSE: NUVB), a biopharmaceutical company tackling some of the greatest unmet needs in oncology by developing differentiated and novel therapeutic candidates, and AnHeart Therapeutics Ltd. (AnHeart), a global clinical-stage biopharmaceutical company developing novel precision therapies for people with cancer, today announced that the companies have entered into a definitive agreement for Nuvation Bio to acquire AnHeart in an all-stock transaction (the Acquisition).
Immediately following the closing of the Acquisition, the former shareholders of AnHeart will own approximately 33% and the current stockholders of Nuvation Bio will own approximately 67% of Nuvation Bio on a fully diluted basis.
Subject to approval by the Nuvation Bio stockholders (the Nuvation Bio Stockholder Approval), each share of Series A Non-Voting Convertible Preferred Stock issued by Nuvation Bio in the Acquisition will initially be convertible into 100 shares of Class A common stock.
Any shareholders of AnHeart who are not accredited investors will receive cash for their AnHeart shares in lieu of receiving Nuvation Bio securities.

AM Best Affirms Credit Ratings of North End Re Ltd.

Retrieved on:

星期三, 三月 13, 2024

Professional Services, Insurance, Finance, Risk management, ALL, SPC, News, Credit, Investment, AM Best, Cayman

The ratings reflect North End Re Ltd.’s balance sheet strength, which AM Best assesses as strong, as well as its adequate operating performance, neutral business profile and appropriate enterprise risk management.

Key Points:

The ratings reflect North End Re Ltd.’s balance sheet strength, which AM Best assesses as strong, as well as its adequate operating performance, neutral business profile and appropriate enterprise risk management.
North End Re Ltd. geographically complements its sister companies, North End Re (Cayman) SPC, and Brookfield Annuity Company, which provides pension risk transfer solutions in Canada.
For additional information regarding the use and limitations of Credit Rating opinions, please view Guide to Best's Credit Ratings .
For information on the proper use of Best’s Credit Ratings, Best’s Performance Assessments, Best’s Preliminary Credit Assessments and AM Best press releases, please view Guide to Proper Use of Best’s Ratings & Assessments .

CASI PHARMACEUTICALS ANNOUNCES FOURTH QUARTER AND FULL-YEAR 2023 BUSINESS AND FINANCIAL RESULTS

Retrieved on:

星期四, 三月 28, 2024

BEIJING, March 28, 2024 /PRNewswire/ -- CASI Pharmaceuticals, Inc. (Nasdaq: CASI), a Cayman incorporated biopharmaceutical company focused on developing and commercializing innovative therapeutics and pharmaceutical products, today reported business and financial results for the year ended December 31, 2023, and provided an update on key highlights for 2023.

Key Points:

BEIJING, March 28, 2024 /PRNewswire/ -- CASI Pharmaceuticals, Inc. (Nasdaq: CASI), a Cayman incorporated biopharmaceutical company focused on developing and commercializing innovative therapeutics and pharmaceutical products, today reported business and financial results for the year ended December 31, 2023, and provided an update on key highlights for 2023.
CASI reported fourth quarter 2023 revenue of $6.9 million for EVOMELA®, 33% lower than the same period in 2022.
2023 marks a major milestone for CASI and our partner Juventas; Inaticabtagene Autoleucel (CNCT-19 CAR-T cell therapy) was approved by National Medical Products Administration (NMPA) in November 2023.
As of December 31, 2023, CASI had cash, cash equivalents and short term investment of $29.1 million compared to $48.6 million as of December 31, 2022.

FG Financial Group, Inc. and FG Group Holdings Inc. Complete Merger

Retrieved on:

星期四, 二月 29, 2024

CFO, Asset management, Merchant bank, FGF, Cayman, FG

Mooresville, NC, Feb. 29, 2024 (GLOBE NEWSWIRE) -- FG Financial Group, Inc. (Nasdaq: FGF, FGFPP) (“FG Financial”) and FG Group Holdings Inc. (“FG Group Holdings”) today announced that they have completed the previously announced merger pursuant to which FG Group Holdings merged with and into FG Group LLC, with FG Group LLC surviving as a wholly-owned subsidiary of FG Financial. In connection with the merger, FG Group Holdings’ stockholders received one share of FG Financial common stock in exchange for each share of FG Group Holdings common stock. Following the merger, FG Financial changed its name to Fundamental Global Inc. (“Fundamental Global” or the “Company”). The Company’s common stock and Series A cumulative preferred stock will continue to trade on the Nasdaq under the tickers “FGF” and “FGFPP,” respectively.

Key Points:

Renamed to Fundamental Global Inc.
Mooresville, NC, Feb. 29, 2024 (GLOBE NEWSWIRE) -- FG Financial Group, Inc. (Nasdaq: FGF, FGFPP) (“FG Financial”) and FG Group Holdings Inc. (“FG Group Holdings”) today announced that they have completed the previously announced merger pursuant to which FG Group Holdings merged with and into FG Group LLC, with FG Group LLC surviving as a wholly-owned subsidiary of FG Financial.
In connection with the merger, FG Group Holdings’ stockholders received one share of FG Financial common stock in exchange for each share of FG Group Holdings common stock.
Following the merger, FG Financial changed its name to Fundamental Global Inc. (“Fundamental Global” or the “Company”).
FG Group Holdings shareholders were resoundingly in favor of this transaction, with 99.9% of the consents returned voting in favor of the plan of merger.

FG Financial Group, Inc. and FG Group Holdings Inc. Complete Merger

Retrieved on:

星期四, 二月 29, 2024

CFO, Asset management, Merchant bank, FGF, Cayman, FG

Mooresville, NC, Feb. 29, 2024 (GLOBE NEWSWIRE) -- FG Financial Group, Inc. (Nasdaq: FGF, FGFPP) (“FG Financial”) and FG Group Holdings Inc. (“FG Group Holdings”) today announced that they have completed the previously announced merger pursuant to which FG Group Holdings merged with and into FG Group LLC, with FG Group LLC surviving as a wholly-owned subsidiary of FG Financial. In connection with the merger, FG Group Holdings’ stockholders received one share of FG Financial common stock in exchange for each share of FG Group Holdings common stock. Following the merger, FG Financial changed its name to Fundamental Global Inc. (“Fundamental Global” or the “Company”). The Company’s common stock and Series A cumulative preferred stock will continue to trade on the Nasdaq under the tickers “FGF” and “FGFPP,” respectively.

Key Points:

Renamed to Fundamental Global Inc.
Mooresville, NC, Feb. 29, 2024 (GLOBE NEWSWIRE) -- FG Financial Group, Inc. (Nasdaq: FGF, FGFPP) (“FG Financial”) and FG Group Holdings Inc. (“FG Group Holdings”) today announced that they have completed the previously announced merger pursuant to which FG Group Holdings merged with and into FG Group LLC, with FG Group LLC surviving as a wholly-owned subsidiary of FG Financial.
In connection with the merger, FG Group Holdings’ stockholders received one share of FG Financial common stock in exchange for each share of FG Group Holdings common stock.
Following the merger, FG Financial changed its name to Fundamental Global Inc. (“Fundamental Global” or the “Company”).
FG Group Holdings shareholders were resoundingly in favor of this transaction, with 99.9% of the consents returned voting in favor of the plan of merger.